First-in-class Oral IRF5 Degrader, KT-579, Demonstrates Selective and Potent In Vitro and In Vivo Activity in Human Cellular Assays and Mouse Models of Lupus

First-in-class Oral IRF5 Degrader, KT-579, Demonstrates Selective and Potent In Vitro and In Vivo Activity in Human Cellular Assays and Mouse Models of Lupus

European Alliance of Associations for Rheumatology (EULAR) 2026

Veronica Campbell, Erik Corcoran, Emily Lurier, Yi Zhang, Virginia Massa, Jordan Leedberg, Chris Caroll, Chris Ho, Dapeng Chen, Matthew Lalonde, Revonda Mehovic, Ziyan Zhao, Charles Howarth, Susanne Breitkopf, Sarah Martinez, Melissa Ford, Xue Fei, Murugappan Sathappa, Juliet Williams, Matt Weiss, Nello Mainolfi